Controversial cardiovascular and hematologic comorbidities in atopic dermatitis
- 10 May 2021
- journal article
- review article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 314 (4) , 317-324
Abstract
Atopic dermatitis’ (AD) systemic involvement is wide-reaching. The cardiovascular and hematological comorbidities of AD have potential for considerable economic and physical burden; however, data surrounding the association between these comorbidities and AD is controversial. This review discusses the cardiovascular and hematological comorbidities of AD, detailing the conflicting evidence, pathophysiology, and connection to medications. A PubMed search was conducted for studies detailing the association of cardiovascular and hematological comorbidities with AD, providing approximately 30 results. Additional searches were conducted for studies discussing the pathophysiology of these comorbidities and possible connections to AD medications. Various studies highlight either positive, negative, or no association of AD with hypertension, stroke, myocardial infarction, heart failure, and thrombosis. Coronary heart disease, angina, peripheral artery disease, and anemia are consistently positively associated with AD. However, the attributable risks of AD for stroke, myocardial infarction, heart failure, and atrial fibrillation are low (25 per 100,000 persons [99% CI 6–44], 12 per 100,000 persons [99% CI − 4–27], 40 per 100,000 persons [99% CI 22–57], and 37 per 100,000 persons [99% CI 15–55]), respectively. The pathophysiology underlying these potential associations is not entirely clear. Corticosteroids, cyclosporine, and antimetabolites, all used to treat AD, may also be associated with many of these comorbidities. AD’s controversial associations with cardiovascular and hematological diseases complicates management as it is difficult to define recommendations for screening of these comorbidities. A better understanding may help lessen the economic and physical burden of these comorbidities in AD patients.Keywords
This publication has 41 references indexed in Scilit:
- Interleukin‐13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotypeEMBO Molecular Medicine, 2012
- IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe–/– miceJournal of Clinical Investigation, 2011
- Tacrolimus ointment in the management of atopic dermatitisClinical, Cosmetic and Investigational Dermatology, 2009
- The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case–control analysisArthritis & Rheumatism, 2008
- Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyArthritis Research & Therapy, 2008
- Elevated Platelet Activation in Patients with Atopic Dermatitis and Psoriasis: Increased Plasma Levels of β-Thromboglobulin and Platelet Factor 4Allergology International, 2008
- Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritisRheumatology, 2008
- Efficacy and safety of long‐term treatment with cyclosporin A for atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 2006
- Tryptase genetics and anaphylaxisJournal of Allergy and Clinical Immunology, 2006
- Glucocorticoid treatment and cardiovascular diseaseHeart, 2004